Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)

NCT05310227 · clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped The device became FDA approved during enrollment thereby nullifying the need to complete the trial. No clinical data was collected.

Conditions

Interventions

Sponsor

Children's National Research Institute

Collaborators